GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Safe Fertility Group PCL (BKK:SAFE) » Definitions » EV-to-EBITDA

Safe Fertility Group PCL (BKK:SAFE) EV-to-EBITDA : 18.19 (As of Oct. 09, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Safe Fertility Group PCL EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Safe Fertility Group PCL's enterprise value is ฿3,189.9 Mil. Safe Fertility Group PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was ฿175.4 Mil. Therefore, Safe Fertility Group PCL's EV-to-EBITDA for today is 18.19.

The historical rank and industry rank for Safe Fertility Group PCL's EV-to-EBITDA or its related term are showing as below:

BKK:SAFE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.32   Med: 20.69   Max: 28.11
Current: 18.18

During the past 3 years, the highest EV-to-EBITDA of Safe Fertility Group PCL was 28.11. The lowest was 11.32. And the median was 20.69.

BKK:SAFE's EV-to-EBITDA is ranked worse than
65.42% of 480 companies
in the Healthcare Providers & Services industry
Industry Median: 12.945 vs BKK:SAFE: 18.18

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-10-09), Safe Fertility Group PCL's stock price is ฿15.40. Safe Fertility Group PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was ฿0.849. Therefore, Safe Fertility Group PCL's PE Ratio (TTM) for today is 18.14.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Safe Fertility Group PCL EV-to-EBITDA Historical Data

The historical data trend for Safe Fertility Group PCL's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Safe Fertility Group PCL EV-to-EBITDA Chart

Safe Fertility Group PCL Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
- - 13.49

Safe Fertility Group PCL Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
EV-to-EBITDA Get a 7-Day Free Trial - - 13.49 27.75 22.26

Competitive Comparison of Safe Fertility Group PCL's EV-to-EBITDA

For the Medical Care Facilities subindustry, Safe Fertility Group PCL's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Safe Fertility Group PCL's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Safe Fertility Group PCL's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Safe Fertility Group PCL's EV-to-EBITDA falls into.



Safe Fertility Group PCL EV-to-EBITDA Calculation

Safe Fertility Group PCL's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3189.911/175.414
=18.19

Safe Fertility Group PCL's current Enterprise Value is ฿3,189.9 Mil.
Safe Fertility Group PCL's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿175.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Safe Fertility Group PCL  (BKK:SAFE) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Safe Fertility Group PCL's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=15.40/0.849
=18.14

Safe Fertility Group PCL's share price for today is ฿15.40.
Safe Fertility Group PCL's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿0.849.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Safe Fertility Group PCL EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Safe Fertility Group PCL's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Safe Fertility Group PCL Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Ploenchit Road, No. 496, 498, 500, 502 , Amarin Plaza Building, 16-18th Floor, Lumpini, Pathumwan, Bangkok, THA, 10330
Safe Fertility Group PCL operations include Obstetrics and Gynecology hospital and Medical laboratory and Cosmetic dermatology. Majority of the revenue is generated from Obstetrics and Gynecology hospital business segment and provides treatment services for infertility using medical assisted reproductive technology.